Medical AI business ‘Dr.Answer’vaiim2020-09-04T18:06:59+00:00
Promoted ‘Dr. Answer’ business with the aim of developing Korean medical AI software and set up ‘AI-based precision medicine solution bureau’, led by NIPA(National IT Industry Promotion Agency) and participated in 26 hospitals and 22 institutions.
Epilepsy and dementia were managed by SNUH/SNUBH, and unlike other diseases, commercialization was being considered from the service design stage.
Participated in epilepsy and dementia related AI software service design and commercialization strategy establishment.
Conducted basic service concept design, flow design & decomposition and detailed function defining, which are reflected clinical demand and treatment process.
Estimated market size, researched law/regulation, and competitors, set the main target and established target approach strategies.
Supported licensing process and designed business structure.
Established demonstration plans and supported for implementation of AI software, involving domestic 7 leading hospitals and 2 medium hospitals and MNG-HA affiliated hospital in Kingdom of Saudi Arabia.
Performed as PMO with NIPA and ezCaretech at the KSA hospital demonstration.
AI software license for Epilepsy(class 2 medical device) and dementia(class 3 medical device) is in progress.
Planned to spread and commercialization after the demonstration of domestic and overseas(MNG-HA affiliated hospital in KSA) in 2020.